Skip to main content

Videos

September 29, 2020
Bernhard T. Baune, PhD, MD, head of the Department of Mental Health at the University of Münster, Germany, discusses the research needed to improve clinicians' understanding of cognition in patients…
September 23, 2020
Joseph F. Goldberg, MD, explains the role of antidepressants in the treatment of bipolar disorder, including when their use may be acceptable and when they should be avoided.
September 22, 2020
Psych Congress 2020 cochair Vladimir Maletic, MD, MS, discusses the risks associated with comorbid conditions in patients with attention deficit/hyperactivity disorder (ADHD) and strategies for…
September 21, 2020
Bernhard T. Baune, PhD, MD, of the University of Münster, Germany, discusses pharmacological treatments that may improve cognition in patients with major depressive disorder.
September 13, 2020
Psych Congress 2020 speaker Joseph F. Goldberg, MD, details factors that could influence a patient's response to a treatment for bipolar disorder, and how clinicians can address them.
September 13, 2020
Psych Congress 2020 presenter Timothy Wilens, MD, discusses the ways in which early treatment can improve outcomes in patients with attention-deficit/hyperactivity disorder (ADHD). 
September 13, 2020
Psych Congress 2020 speaker Marc E. Agronin, MD, shares strategies that mental health clinicians can use to adjust psychopharmacologic treatment and dosages for geriatric patients.
September 12, 2020
Bernhard T. Baune, PhD, MD, head of the Department of Mental Health at the University of Münster, Germany, discusses the occurrence of cognitive deficits in patients with various psychiatric…
September 12, 2020
Psych Congress 2020 cochair Vladimir Maletic, MD, MS, gives the latest updates on adult-onset attention deficit/hyperactivity disorder (ADHD).
September 12, 2020
Psych Congress 2020 presenter Timothy Wilens, MD, discusses the negative outcomes associated with attention-deficit/hyperactivity disorder (ADHD) that is left untreated.
Back to Top